BridgeBio Pharma, Inc.
Hedge Funds Holdings
Last updated:
BridgeBio Pharma, Inc.‘s stocks are currently a part of 157 hedge funds’ portfolios, which represents 90.82% of the total amount of its stocks outstanding. This makes up a total of 133.22M shares of BridgeBio Pharma, Inc.. Compared to the previous quarter, the number fell by -4.47% or -6.22M shares fewer. As for the holding position changes, 41.4% (65) of current hedge fund investors increased the number of shares held, 28.03% (44) of current holders sold a part of the shares held, and 5.1% (8) closed the holdings completely. 23 hedge funds are new holders of BridgeBio Pharma, Inc. stock in Q3 2022, it is 14.65% of total holders.
Hedge funds holding BridgeBio Pharma (Q2 2019 – Q3 2022)
| Q2 2019 | 61 |
|---|---|
| Q3 2019 | 74 |
| Q4 2019 | 86 |
| Q1 2020 | 94 |
| Q2 2020 | 115 |
| Q3 2020 | 128 |
| Q4 2020 | 159 |
| Q1 2021 | 196 |
| Q2 2021 | 199 |
| Q3 2021 | 207 |
| Q4 2021 | 186 |
| Q1 2022 | 168 |
| Q2 2022 | 153 |
| Q3 2022 | 157 |
Hedge funds changes in BridgeBio Pharma positions (Q2 2019 – Q3 2022)
| Q2 2019 | 61 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2019 | 32 | 18 | 15 | 18 | -9 |
| Q4 2019 | 28 | 30 | 16 | 10 | 2 |
| Q1 2020 | 25 | 41 | 17 | 15 | -4 |
| Q2 2020 | 32 | 43 | 23 | 11 | 6 |
| Q3 2020 | 26 | 36 | 48 | 13 | 5 |
| Q4 2020 | 42 | 64 | 37 | 11 | 5 |
| Q1 2021 | 60 | 89 | 39 | 22 | -14 |
| Q2 2021 | 30 | 81 | 60 | 26 | 2 |
| Q3 2021 | 29 | 82 | 61 | 18 | 17 |
| Q4 2021 | 33 | 72 | 63 | 54 | -36 |
| Q1 2022 | 42 | 45 | 56 | 57 | -32 |
| Q2 2022 | 15 | 57 | 55 | 26 | 0 |
| Q3 2022 | 23 | 65 | 44 | 8 | 17 |
Hedge funds changes in BridgeBio Pharma stock options (Q2 2019 – Q3 2022)
| Q2 2019 | 0 | 0 |
|---|---|---|
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 11,102,166 | 2,086,103 |
| Q2 2020 | 28,672,000 | 743,000 |
| Q3 2020 | 2,886,000 | 1,834,000 |
| Q4 2020 | 27,670,000 | 8,418,000 |
| Q1 2021 | 20,777,000 | 44,062,000 |
| Q2 2021 | 19,191,000 | 48,523,000 |
| Q3 2021 | 19,620,000 | 40,249,000 |
| Q4 2021 | 121,854,000 | 72,839,000 |
| Q1 2022 | 10,169,000 | 4,174,000 |
| Q2 2022 | 9,023,000 | 3,531,000 |
| Q3 2022 | 3,366,000 | 2,632,000 |